Founders Financial Alliance’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Founders Financial Alliance's BMY Position: Q1 2026 in Review
Founders Financial Alliance increased its Bristol-Myers Squibb (BMY) stake by 17% in Q1 2026, buying an estimated $78.5K and bringing the position to 9,145 shares worth $555K. The position accounts for 0.1% of the portfolio, ranked #193.
Founders Financial Alliance first reported a position in BMY in Q3 2020 and has held it in 23 quarters since. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Founders Financial Alliance held 9,145 shares of Bristol-Myers Squibb worth $555K as of Q1 2026.
- Founders Financial Alliance bought 1,347 Bristol-Myers Squibb shares in Q1 2026, an estimated $78.5K.
- Bristol-Myers Squibb made up 0.1% of Founders Financial Alliance's portfolio in Q1 2026, its #193 holding.
- Founders Financial Alliance first reported a position in Bristol-Myers Squibb in Q3 2020 and has held it in 23 quarters since.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Founders Financial Alliance's 13F filing for Q1 2026, filed 11 May 2026.